Search Results - "Casafont, Ivette"
-
1
Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis—multicentre study of 263 Caucasian patients
Published in Rheumatology (Oxford, England) (24-12-2021)“…Abstract Objective To assess the efficacy and safety of abatacept (ABA) in monotherapy (ABAMONO) vs combined ABA [ABA plus MTX (ABAMTX) or ABA plus non-MTX…”
Get full text
Journal Article -
2
Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection
Published in European journal of immunology (01-01-2024)“…In COVID‐19, hyperinflammatory and dysregulated immune responses contribute to severity. Patients with pre‐existing autoimmune conditions can therefore be at…”
Get full text
Journal Article -
3
Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease
Published in Annals of the rheumatic diseases (01-05-2020)“…To analyse the association between anti-carbamylated protein antibodies (Anti-CarP) and interstitial lung disease (ILD) in rheumatoid arthritis (RA) patients…”
Get more information
Journal Article -
4
Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis
Published in European journal of internal medicine (01-01-2024)“…To compare the effectiveness of abatacept (ABA) in Rheumatoid Arthritis-associated Interstitial Lung Disease (RA-ILD) according to the radiological patterns of…”
Get full text
Journal Article -
5
IgA vasculitis and polymyalgia rheumatica induced by durvalumab
Published in Translational lung cancer research (01-04-2020)Get full text
Journal Article -
6
Vagus nerve dysfunction in the post-COVID-19 condition: a pilot cross-sectional study
Published in Clinical microbiology and infection (01-04-2024)“…The post-COVID-19 condition (PCC) is a disabling syndrome affecting at least 5%-10% of subjects who survive COVID-19. SARS-CoV-2 mediated vagus nerve…”
Get more information
Journal Article -
7
O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort
Published in Lupus science & medicine (14-03-2024)“…ObjectivesBelimumab (BLM) had been shown to be consistently effective in patients with systemic lupus erythematosus (SLE) and is increasingly being used…”
Get full text
Journal Article -
8
P147 Is belimumab dose optimization possible in patients with systemic lupus erythematosus? Analysis of this therapeutic strategy in a large multicenter cohort of patients from Spanish rheumatology departments
Published in Lupus science & medicine (14-03-2024)“…ObjectiveTo assess the prevalence of dose optimization in patients with SLE treated with BLM, its modalities and its impact on disease activity…”
Get full text
Journal Article -
9
LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort
Published in Lupus science & medicine (01-07-2023)“…BackgroundBaseline profile of systemic lupus erythematosus patients on treatment with Belimumab of a Spanish multicenter cohort.MethodsMulticenter…”
Get full text
Journal Article -
10
Heart⁻Lung⁻Muscle Anti-SAE Syndrome: An Atypical Severe Combination
Published in Journal of clinical medicine (23-12-2018)“…A 78-year-old man with 3 months of progressive dyspnea, dysphony, dysgeusia, and proximal muscle weakness was diagnosed of probably idiopathic inflammatory…”
Get full text
Journal Article -
11
Can the Dose of Belimumab be Reduced in Patients with Systemic Lupus Erythematosus?
Published in Rheumatology (Oxford, England) (13-05-2024)“…The aims of this study were to investigate the prevalence of dose reduction in patients with SLE treated with belimumab (BEL) in Spain, analyze treatment…”
Get full text
Journal Article -
12
Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients
Published in Rheumatology (Oxford, England) (15-03-2024)“…To provide an overview on the current use of belimumab (BLM) in SLE patients in clinical practice and to examine its efficacy in terms of standardized…”
Get full text
Journal Article -
13
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients
Published in Seminars in arthritis and rheumatism (01-10-2024)“…Evidence on abatacept (ABA) utility for rheumatoid arthritis (RA) – associated interstitial lung disease (ILD) is growing. Clinical trials have shown…”
Get full text
Journal Article -
14
Heart⁻Lung⁻Muscle Anti-SAE Syndrome: An Atypical Severe Combination
Published in Journal of clinical medicine (23-12-2018)Get full text
Report